Cryocell India Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 4.03 M
- Company Age 23 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -2.54%
- Profit Growth -7.90%
- Ebitda 32.56%
- Net Worth 6.67%
- Total Assets 6.93%
About Cryocell India
Cryocell India Private Limited (CIPL) is a Private Limited Indian Non-Government Company incorporated in India on 26 February 2001 and has a history of 23 years and 11 months. Its registered office is in Delhi, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 4.03 M, as per Ministry of Corporate Affairs (MCA) records.
Suryakant Hayatnagarkar and Rajnish Sehgal serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74899DL2001PTC109813
-
Company No.
109813
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
26 Feb 2001
-
Date of AGM
26 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Cryocell India?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Suryakant Hayatnagarkar
|
Director | 26-Feb-2001 | Current |
|
Rajnish Sehgal
|
Director | 26-Feb-2001 | Current |
Financial Performance of Cryocell India.
Cryocell India Private Limited, for the financial year ended 2020, experienced Minor drop in revenue, with a 2.54% decrease. The company also saw a slight decrease in profitability, with a 7.9% decrease in profit. The company's net worth moved up by a moderate rise of 6.67%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cryocell India?
In 2020, Cryocell India had a promoter holding of 99.26% and a public holding of 0.74%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Vspsamruddh Bio-Tech LlpSuryakant Hayatnagarkar is a mutual person
-
Gadgets & Gizmos Infratech Private Limited
Rajnish Sehgal is a mutual person
-
Cell Mate Cryopreservation Private Limited
Rajnish Sehgal is a mutual person
-
Regen Medtec Private Limited
Rajnish Sehgal is a mutual person
-
Et Ipsum 360 Private Limited
Rajnish Sehgal is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Cryocell India?
Unlock and access historical data on people associated with Cryocell India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cryocell India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cryocell India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.